To determine whether SPRR2A could be used as a potential diagnostic marker for GC prior to surgery, we collected blood samples from 72 patients with GC before and after surgery, and differential SPRR2A expression was analyzed. This evidence concerns the gene SPRR2A and gastric cancer.